Correlation Between Cannara Biotech and Australis Capital
Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and Australis Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and Australis Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannara Biotech and Australis Capital, you can compare the effects of market volatilities on Cannara Biotech and Australis Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of Australis Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and Australis Capital.
Diversification Opportunities for Cannara Biotech and Australis Capital
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cannara and Australis is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and Australis Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Australis Capital and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with Australis Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Australis Capital has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and Australis Capital go up and down completely randomly.
Pair Corralation between Cannara Biotech and Australis Capital
Assuming the 90 days horizon Cannara Biotech is expected to under-perform the Australis Capital. But the otc stock apears to be less risky and, when comparing its historical volatility, Cannara Biotech is 5.66 times less risky than Australis Capital. The otc stock trades about -0.07 of its potential returns per unit of risk. The Australis Capital is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 0.01 in Australis Capital on August 24, 2024 and sell it today you would earn a total of 0.00 from holding Australis Capital or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cannara Biotech vs. Australis Capital
Performance |
| Timeline |
| Cannara Biotech |
| Australis Capital |
Cannara Biotech and Australis Capital Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cannara Biotech and Australis Capital
The main advantage of trading using opposite Cannara Biotech and Australis Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, Australis Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Australis Capital will offset losses from the drop in Australis Capital's long position.| Cannara Biotech vs. Benchmark Botanics | Cannara Biotech vs. Speakeasy Cannabis Club | Cannara Biotech vs. City View Green | Cannara Biotech vs. BC Craft Supply |
| Australis Capital vs. Body and Mind | Australis Capital vs. Radient Technologies | Australis Capital vs. Choom Holdings | Australis Capital vs. Khiron Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |